285 related articles for article (PubMed ID: 24500040)
21. Advances in the treatment of opioid dependence: continued progress and ongoing challenges.
O'Connor PG
JAMA; 2010 Oct; 304(14):1612-4. PubMed ID: 20940391
[No Abstract] [Full Text] [Related]
22. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States.
Cicero TJ; Surratt H; Inciardi JA; Munoz A
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):827-40. PubMed ID: 17636553
[TBL] [Abstract][Full Text] [Related]
23. Telemedicine's Role in Addressing the Opioid Epidemic.
Yang YT; Weintraub E; Haffajee RL
Mayo Clin Proc; 2018 Sep; 93(9):1177-1180. PubMed ID: 30097301
[No Abstract] [Full Text] [Related]
24. Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment.
Madden A; Lea T; Bath N; Winstock AR
Drug Alcohol Rev; 2008 Nov; 27(6):671-8. PubMed ID: 19378450
[TBL] [Abstract][Full Text] [Related]
25. Commentary on Freelemyer et al. (2014): medication-assisted treatment in Africa-need is growing but response remains tepid.
Obot IS
Addiction; 2014 Jan; 109(1):33-4. PubMed ID: 24438111
[No Abstract] [Full Text] [Related]
26. Medication-assisted recovery from opioid addiction: historical and contemporary perspectives.
White WL
J Addict Dis; 2012; 31(3):199-206. PubMed ID: 22873182
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
[TBL] [Abstract][Full Text] [Related]
28. What more do we need to know about medication-assisted treatment for prescription opioid abusers?
Magura S
Addiction; 2009 May; 104(5):784-5. PubMed ID: 19413789
[No Abstract] [Full Text] [Related]
29. Opioid treatment in Ukraine risks losing momentum.
Bull World Health Organ; 2013 Feb; 91(2):87-8. PubMed ID: 23554519
[TBL] [Abstract][Full Text] [Related]
30. Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11.
Dick AW; Pacula RL; Gordon AJ; Sorbero M; Burns RM; Leslie D; Stein BD
Health Aff (Millwood); 2015 Jun; 34(6):1028-34. PubMed ID: 26056209
[TBL] [Abstract][Full Text] [Related]
31. Prescription opioid abuse among enrollees into methadone maintenance treatment.
Rosenblum A; Parrino M; Schnoll SH; Fong C; Maxwell C; Cleland CM; Magura S; Haddox JD
Drug Alcohol Depend; 2007 Sep; 90(1):64-71. PubMed ID: 17386981
[TBL] [Abstract][Full Text] [Related]
32. Reducing stigma through education to enhance Medication-Assisted Recovery.
Woods JS; Joseph H
J Addict Dis; 2012; 31(3):226-35. PubMed ID: 22873184
[TBL] [Abstract][Full Text] [Related]
33. The evidence doesn't justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphine.
Clark RE; Samnaliev M; Baxter JD; Leung GY
Health Aff (Millwood); 2011 Aug; 30(8):1425-33. PubMed ID: 21821560
[TBL] [Abstract][Full Text] [Related]
34. Chronic opioid use during pregnancy: maternal and fetal implications.
Stanhope TJ; Gill LA; Rose C
Clin Perinatol; 2013 Sep; 40(3):337-50. PubMed ID: 23972743
[TBL] [Abstract][Full Text] [Related]
35. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
[TBL] [Abstract][Full Text] [Related]
36. Opioid substitution treatment in New Zealand: a 40 year perspective.
Deering D; Sellman JD; Adamson S
N Z Med J; 2014 Jul; 127(1397):57-66. PubMed ID: 24997702
[TBL] [Abstract][Full Text] [Related]
37. Opioid substitution and HIV/AIDS treatment and prevention.
Kerr T; Wodak A; Elliott R; Montaner JS; Wood E
Lancet; 2004 Nov 27-Dec 3; 364(9449):1918-9. PubMed ID: 15566992
[No Abstract] [Full Text] [Related]
38. Abstinence orientation and treatment practice: an analysis of German settings providing opioid maintenance therapy.
Trautmann S; Wittchen HU
Subst Use Misuse; 2012 Jan; 47(1):22-30. PubMed ID: 22060728
[TBL] [Abstract][Full Text] [Related]
39. The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia.
Horyniak D; Dietze P; Larance B; Winstock A; Degenhardt L
Int J Drug Policy; 2011 Mar; 22(2):167-71. PubMed ID: 21112758
[TBL] [Abstract][Full Text] [Related]
40. Staring down the opioid epidemic.
Unger JR
J Fam Pract; 2017 Jan; 66(1):8. PubMed ID: 28188310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
